Chromatography Data System: Business and GMP Functions, Architectural Components, and Lifecycle Compliance
Overview
This coursework examines Chromatography Data Systems (CDS) and their role in pharmaceutical quality assurance and regulatory compliance. The paper identifies GMP functions and business requirements for electronic record management, describes system architectural components, and outlines a lifecycle compliance approach including concept, project operation, and retirement phases.
What this coursework covers
- Business and GMP functions of CDS with emphasis on electronic records, traceability, and HPLC data management
- Design history files (DHF) and FDA regulatory requirements for complaint reporting
- Schematic representation of typical architectural components
- Lifecycle compliance strategy using V-model approach across concept, project, operation, and retirement phases
Preview
CHROMATOGRAPHY DATA SYSTEM (CDS)
Student’s Name
Course
Professor
Affiliation
City
State
Date
Chromatography Data System (CDS)
- Identify and describe the typical business and GMP functions (20%)
Electronic records are essential in providing traceability, which play significant roles in business and GMP functions. HPLC is involved in retaining run-time data files, which result from approved analytical techniques. Some of the run-time data that requires recording are sample/standard sequences (analytical methods), detector conditions such as wavelength, column temperature, and solvent flow, among others. According to Gerladine (2020), chromatographic data is usually moved to CDS to facilitate data analysis and storage rather than being retained in the HPLC system. The records act as medium impact as it is the mandate of management to determine the final decisions. Design history file (DHF) describes a combination of files that tend to explain the history of finished devices (Marehn, Wilhelm, Pospisil & Pizzoferrato, 2019). The final device review will include concepts such as design identification, person and date of the review, and documented in the DHF (Aziz 2019). Any complaint related to an event is usually reported to the FDA under part803 or 804 (Aziz 2019).
A record is usually verified if trustworthy, depending on whether the systems can verify its integrity and authenticity after copying, transferring, migrating, or reformatting the record to ensure no alteration. In essence, it is necessary to consider the trustworthiness and integrity of a record when sharing information objects between several computing environments.